Orion Marine Group (ORN)
12.92
-0.23 (1.75%)
Upcoming Events
Latest Headlines
Orion Group Holdings to Report Second Quarter 2026 Financial Results on Tuesday, July 28, 2026
July 14, 2026 4:05 PM - StreetInsider
ORYZON Announces U.S. Patent Grant for Vafidemstat in Borderline Personality Disorder (BPD)
July 8, 2026 8:00 AM - Globe NewsWire
Oppenheimer Starts Orion Marine Group (ORN) at Outperform
July 7, 2026 6:11 AM - StreetInsider
Oryzon raises €12M in share offering, secures €25M COFIDES commitment
July 1, 2026 9:09 AM - StreetInsider
ORYZON Raises €12 Million and Signs a Financing Agreement with COFIDES to Strengthen its Balance Sheet and Accelerate its Clinical Programs
July 1, 2026 9:08 AM - Globe NewsWire
Form 4 Orion Group Holdings For: Jun 23 Filed by: Vasquez Alison Gaut
June 25, 2026 6:46 PM - SEC Filing
ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress
June 11, 2026 8:00 AM - Globe NewsWire
Freedom Broker Starts Orion Marine Group (ORN) at Buy
June 2, 2026 9:19 AM - StreetInsider
ORYZON Initiates Patient Enrollment in IDEAL Phase II Trial of Iadademstat in Essential Thrombocythemia
June 2, 2026 8:01 AM - Globe NewsWire
Form 4 Orion Group Holdings For: May 19 Filed by: LEDFORD ROBERT
May 20, 2026 5:57 PM - SEC Filing
Form 4 Orion Group Holdings For: May 19 Filed by: Smith Quentin P. Jr.
May 20, 2026 5:56 PM - SEC Filing
Form 4 Orion Group Holdings For: May 19 Filed by: Sullivan Mary E
May 20, 2026 5:55 PM - SEC Filing
Form 4 Orion Group Holdings For: May 19 Filed by: SHANFELTER AUSTIN J
May 20, 2026 5:54 PM - SEC Filing
Form 4 Orion Group Holdings For: May 19 Filed by: Caliel Michael J
May 20, 2026 5:53 PM - SEC Filing
Form S-8 Orion Group Holdings
May 20, 2026 5:16 PM - SEC Filing
Form 8-K Orion Group Holdings For: May 19
May 20, 2026 5:04 PM - SEC Filing
Orion Group Holdings Announces Conference Participation
May 18, 2026 7:00 AM - Globe NewsWire
Orion Marine Group (ORN) PT Raised to $19 at JPMorgan
May 15, 2026 3:34 AM - StreetInsider
ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026
May 14, 2026 10:47 AM - Globe NewsWire
ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026
May 13, 2026 8:00 AM - Globe NewsWire
Form 4 Orion Group Holdings For: May 05 Filed by: FORAN MARGARET M
May 6, 2026 8:22 PM - SEC Filing
Form 4 Orion Group Holdings For: May 01 Filed by: FORAN MARGARET M
May 4, 2026 6:32 PM - SEC Filing
Form 10-Q Orion Group Holdings For: Mar 31
April 29, 2026 2:37 PM - SEC Filing
Form 8-K Orion Group Holdings For: Apr 28
April 29, 2026 8:35 AM - SEC Filing
ORYZON to Participate in Upcoming Events in May and June
April 29, 2026 8:00 AM - Globe NewsWire
Orion Group Holdings Reports First Quarter 2026 Results
April 28, 2026 4:05 PM - StreetInsider
Full Article List
